News
Ticagrelor/aspirin combo: Fewer repeat strokes and deaths, but more bleeds
- Author:
- Batya Swift Yasgur, MA, LSW
The combination also increased the risk for major hemorrhage, but that increase was small and would not overwhelm the benefit.
News
Prior beta-blockers predict extra burden of heart failure in women with ACS
- Author:
- Batya Swift Yasgur, MA, LSW
“Our provides robust evidence of an interaction between sex and beta-blocker therapy,” said Dr. Raffaele Bugiardini.
News
PCI or not, mortality climbs with post-ACS bleeding complications
- Author:
- Batya Swift Yasgur, MA, LSW
Prevention of bleeding after ACS, whether managed medically or with PCI, should get as much attention as prevention of later ischemic events.
News
Repetitive hits to the head tied to depression, poor cognition in later life
- Author:
- Batya Swift Yasgur, MA, LSW
“What’s unique about our study is that we focused on a history of [repetitive hits to the head],” said Dr. Michael Alosco.
News
Post-PCI mortality higher in Blacks vs. Whites, regardless of comorbidities
- Author:
- Batya Swift Yasgur, MA, LSW
Patients who weren’t White had more comorbidities than did Whites, but that didn’t entirely explain why Blacks fared worse than Whites for...
News
Three stages to COVID-19 brain damage, new review suggests
- Author:
- Batya Swift Yasgur, MA, LSW
Patients with COVID-19 symptoms may have neurological symptoms that may become apparent only after hospital discharge.
News
Do SSRIs raise the risk of violent crime?
- Author:
- Batya Swift Yasgur, MA, LSW
"Our findings should not be used as grounds for individuals to go off their [SSRI] medication," said lead author Tyra Lagerberg, MSc.
News
New guidance to help manage OCD during COVID-19
- Author:
- Batya Swift Yasgur, MA, LSW
Statement emphasizes the importance of using pharmacotherapy as a first-line approach and offering psychoeducation.
News
More evidence hydroxychloroquine is ineffective, harmful in COVID-19
- Author:
- Batya Swift Yasgur, MA, LSW
New observational data show that hydroxychloroquine it is not only without benefit for COVID-19 but also increases death and arrhythmias.